Loading
Latest filing published 21 Jul 2026 for InnoCare Pharma Ltd., €158k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Shi Yigong in InnoCare Pharma Ltd. The record holds 23 filings, for trades running from 15 April 2020 to 17 July 2026.
The open-market side counts 9 purchases alongside 6 sales for €158k. The totals exclude 14 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 3 purchases and 3 sales.
No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 21 July 2026, reports an open-market sale of €158k in InnoCare Pharma Ltd. The clock since the last published purchase (23 June 2026) now reads 123 days. The median gap between a trade and its publication by HKEX is 4 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations